Fumblefinger strikes again!

Sorry about that. Retinopathy, or retinopathological change was what I intended to write.
From another source, a rumour has reached me about yet another drug that just might end up in an athlete near you in the near future. It stems from cancer research. As you know, vascularization of tumors is a prerequisite for tumor growth. The tumor needs oxygen and nutrients to grow. It's well known that hypoxia drives this mechanism, which is why endurance athletes do what they do in training, but there are also other molecular pathways driving tumor vascularization. These molecular pathways have been the subject of tons of research, and being able to starve tumors, blocking capillaries from growing in tumors has been the holy grail. And guess what the flip side of that research is: Knowledge about the molecular pathways that drives increased capillarization and mitochondrial proliferation in muscle tissue! Just wait till the ethically challenged likes of Dr. Ferrari get hold of those chemicals!